Cetirizine hydrochloride — Class III drug recall D-0096-2022
Terminated recall by A-S Medication Solutions LLC., reported 2021-11-17, distributed in FL, IN, MN, WI. Labeling: Not Elsewhere classified: Product was relabeled as 90 tablet count product although it was a manufac
| Recall number | D-0096-2022 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | A-S Medication Solutions LLC., Libertyville, IL, United States |
| Recall initiated | 2021-10-05 |
| Classified | 2021-11-05 |
| Reported by FDA | 2021-11-17 |
| Terminated | 2022-08-12 |
| Distributed | FL, IN, MN, WI |
| Quantity | 72 bottles |
| Reason classes | labeling |
| NDC | 50090-5510, 50090-5510-01, 50090-5510-03 |
| Lot numbers | 1256330 |
Product
Cetirizine hydrochloride, 10 mg tablets, 90-count bottle, Distributed by: A-S Medications Solutions, Libertyville, IL 60048, Mfg: Major Pharmaceuticals, Livonia, MI 48152, NDC: 50090-5510-3
Reason for recall
Labeling: Not Elsewhere classified: Product was relabeled as 90 tablet count product although it was a manufacturer in a box with 30 tablet count tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0096-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.